glp 1 agonist and dementia Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline in Diabetes Mellitus Could diabetes and weight loss

However, they should be discontinued 23 months before conception due to limited safety data during pregnancy

Youll receive nutrition guidance to complement medication and maintain energy

Caloric restriction in humans reveals immunometabolic regulators of health span

To view a copy of this licence, visit About this article Cite this article Dou, J., Cui, Q., Li, W

Acknowledgements This work was partially supported by National Natural Science Foundation of China 81872915 (MWW), 82073904 (MWW), 81773792 (DHY), 81973373 (DHY), and 21704064 (QTZ)

doi: 10.3389/fimmu.2025.1711756 Received 23 September 2025 Accepted 31 October 2025 Published 19 November 2025 Volume 16 - 2025 Edited by Jean-louis Mege, Aix-Marseille Universit, France Reviewed by Nadja Freund, Ruhr University Bochum, Germany Namrata Anand, University of Chicago Medical Center, United States Updates Copyright 2025 Su, Li, Yang, Yang, Wang, Ren, Bao, Lao and Luan